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Novel method to rescue a lethal 
phenotype through integration 
of target gene onto the 
X-chromosome
Kazuya Sakata1,2, Kimi Araki1, Hiroyasu Nakano3, Takashi Nishina3,  
Sachiko Komazawa-Sakon3, Shin Murai3, Grace E. Lee4, Daisuke Hashimoto2, 
Chigure Suzuki5, Yasuo Uchiyama5, Kenji Notohara6, Anna S. Gukovskaya4, Ilya Gukovsky4,  
Ken-ichi Yamamura1, Hideo Baba2 & Masaki Ohmuraya1
The loss-of-function mutations of serine protease inhibitor, Kazal type 1 (SPINK1) gene are associated 
with human chronic pancreatitis, but the underlying mechanisms remain unknown. We previously 
reported that mice lacking Spink3, the murine homologue of human SPINK1, die perinatally due to 
massive pancreatic acinar cell death, precluding investigation of the effects of SPINK1 deficiency. To 
circumvent perinatal lethality, we have developed a novel method to integrate human SPINK1 gene on 
the X chromosome using Cre-loxP technology and thus generated transgenic mice termed “X-SPINK1“. 
Consistent with the fact that one of the two X chromosomes is randomly inactivated, X-SPINK1 mice 
exhibit mosaic pattern of SPINK1 expression. Crossing of X-SPINK1 mice with Spink3+/− mice rescued 
perinatal lethality, but the resulting Spink3−/−;XXSPINK1 mice developed spontaneous pancreatitis 
characterized by chronic inflammation and fibrosis. The results show that mice lacking a gene essential 
for cell survival can be rescued by expressing this gene on the X chromosome. The Spink3−/−;XX SPINK1 
mice, in which this method has been applied to partially restore SPINK1 function, present a novel 
genetic model of chronic pancreatitis.
Trypsin is a major serine protease produced in pancreatic acinar cells as inactive zymogen (trypsinogen). In 
physiological conditions, trypsinogen is secreted by the acinar cells and is cleaved/activated in the duodenum by 
enterokinase, resulting in generation of trypsin1,2. Human serine protease inhibitor, Kazal type 1 (SPINK1) and its 
murine homologue Spink3 play a critical role in suppression of aberrant, intra-acinar/intrapancreatic activation 
of trypsinogen, which is considered a key mechanism preventing the development of pancreatitis3,4. Consistent 
with this concept, loss-of-function mutations of SPINK1 gene are associated with various forms of human chronic 
pancreatitis; however, the mechanisms through which SPINK1 mutations predispose to pancreatitis remain 
elusive5,6. We have previously reported3 that Spink3−/− mice spontaneously develop severe pancreatic damage and 
die within two weeks after birth. The histopathological changes start gradually at embryonic day (E) 16.5 and are 
restricted to pancreatic acinar, but not ductal or islet, cells. The cytoplasm of acinar cells of Spink3−/− mice is filled 
with numerous autophagic vacuoles3, suggesting that Spink3 deletion interferes with autophagy, a key cellular, 
lysosome-driven process that degrades and recycles damaged or unneeded organelles, long-lived proteins, and 
lipids7. The aberrant autophagy could trigger acinar cell death in Spink3−/− mice (it is, however, worth noting that 
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these cells do not display chromatin condensation, a hallmark of apoptosis)3. The early death of Spink3−/− mice 
precludes investigation into the mechanisms of long-term effects of SPINK1 deficiency.
X-chromosome inactivation is a process by which one of the two X chromosomes in female mammals is 
randomly inactivated by packaging into transcriptionally inactive heterochromatin8. Once the X chromosome 
is inactivated, it will remain inactive throughout the lifetime of the cell. During screening of a gene trap library, 
we found that one ES cell line (B210) possessed a trap vector on the X chromosome. By utilizing X-chromosome 
inactivation and the B210 ES cells, we here present a novel method to efficiently integrate a target gene on the X 
chromosome, resulting in a mosaic pattern of the target protein expression. This strategy enabled us to rescue 
perinatal lethality of Spink3−/− mice. The resulting Spink3−/−;XX SPINK1 mice developed spontaneous pancreatitis, 
thus representing a novel genetic model for this disease.
Results
Integration of SPINK1 gene at a locus on X chromosome by using Cre-loxP technology results in 
a mosaic pattern of its expression. Gene-trap mutagenesis is a technique that randomly generates loss-
of-function mutations in many genes9. During gene-trap mutagenesis screening, we found that in one ES cell line 
(designated B210 ES cells) the integrated trap vector inactivated Diaphanous homolog 2 (Diap2) gene on the X 
chromosome10 (Fig. S1a). Diap2, also known as murine Dia3, is one of three members of the Diap family and con-
sidered to play a role in de novo actin filament formation11. Subsequent plasmid rescue and PCR analysis revealed 
that the trap vector was integrated into intron 23 of the Diap2 gene at 50 kbs downstream of exon 23 and 130 kbs 
upstream of exon 27, resulting in deletion of exons 24 to 26 (Fig. S1a,b). We next investigated whether the trap 
vector integration affected the expression of Diap2 protein in B210 ES cells. While Diap2 protein was detected 
in wild-type ES cells, Diap2 protein completely disappeared in B210 cells (Fig. S1c). This suggests that truncated 
mRNA of Diap2 is unstable, causing complete depletion of Diap2 protein. Taken into account that Diap2 (that is, 
Dia3)-deficient mice develop without abnormalities and are fertile11, we reckoned that integration and expression 
of a target gene in the Diap2 locus on X chromosome might be feasible by using Cre-loxP technology; and further, 
that this approach would allow us to express the target gene in a mosaic pattern due to random inactivation of one 
of the two X chromosomes in females.
To this end, we generated a replacement vector containing CAG promoter-human SPINK1 minigene12 flanked 
by two mutated loxP sites, and co-transfected this vector along with a Cre recombinase expression vector13 into 
B210 ES cells (Fig. 1a). We obtained 11 ES cell lines harboring SPINK1 minigene on X chromosome with high 
Figure 1. Generation of human SPINK1 X-chromosome knock-in (“X-SPINK1”) mice. (a) A replacement 
vector containing SPINK1 minigene under the CAG promoter was introduced into Diap2 locus on the X 
chromosome by Cre-loxP technology. (b) RT-PCR analysis of Spink3 and SPINK1 mRNAs in various tissues 
of X-SPINK1 mice at 8 weeks. Acidic ribosomal phosphoprotein P0 (ARP), a “housekeeping” gene control. 
(c) The levels of Spink3 and SPINK1 proteins in various tissues of X-SPINK1 mice at 8 weeks (immunoblot). 
Representative of two independent experiments. (d) ISH analysis of SPINK1 mRNA expression in pancreas of 
mice of the indicated genotype at P0.5. Pancreatic tissue sections were hybridized with Spink3 (upper panels) 
or SPINK1 (middle panels) antisense riboprobes (blue stain). Nuclei stained with Nuclear Fast Red have a pink 
appearance. The bottom right panel is an enlarged image of the boxed area in the panel above. Black and red 
arrows indicate acinar cells with and without SPINK1 expression, respectively. The bottom left and center panels 
show ISH background control using SPINK1 and Spink3 sense riboprobes. Scale bars, 20 μ m. Representative of 
two independent experiments. (e) Pancreas homogenates from mice of the indicated genotype at 8 weeks were 
analyzed by immunoblot analysis. In this and other figures, ERK or tubulin serve as loading control; each lane 
represents an individual animal; and the numbers to the right are protein molecular mass markers in kDa.
www.nature.com/scientificreports/
3Scientific RepoRts | 6:37200 | DOI: 10.1038/srep37200
frequency, and used these ES cells to generate mice termed “X-SPINK1”. Male and female X-SPINK1 mice were 
healthy, fertile, and did not show any abnormalities. These knock-in mice are henceforth referred to as, respec-
tively, X SPINK1Y (male), X SPINK1X SPINK1 (female), and XX SPINK1 (female) mice. We first verified the expression 
of SPINK1 mRNA and protein in X SPINK1Y mice by RT-PCR and immunoblot (IB) analysis. Because SPINK1 
expression in these mice is driven by the ubiquitous CAG promoter, SPINK1 mRNA was ubiquitously expressed 
in various tissues we examined (Fig. 1b). Interestingly, SPINK1 protein expression was restricted to pancreas and, 
to a much lesser extent, stomach and heart (Fig. 1c). The endogenous Spink3 mRNA expression is restricted to 
kidney, pancreas, small and large intestines (Fig. 1b), whereas Spink3 protein is predominantly expressed in the 
pancreas (and to a much lesser extent, large intestine; Fig. 1c).
We next analyzed the expression of SPINK1 mRNA in pancreas of X-SPINK1 mice at 0.5 days after birth 
(P0.5) by in situ hybridization (ISH; Fig. 1d). As expected, all pancreatic acinar cells expressed SPINK1 mRNA 
in X SPINK1Y mice (the wild type Spink3+/+ mice served as negative control). Notably, in XX SPINK1 mice approx-
imately half of acinar cells expressed SPINK1 mRNA (Fig. 1d), consistent with the mosaic pattern of SPINK1 
mRNA expression. The endogenous Spink3 was expressed in all pancreatic acinar cells in X SPINK1Y and XX SPINK1 
mice, same as in Spink3+/+ mice (Fig. 1d). The sense Spink3 or SPINK1 riboprobes were used as a background 
ISH control and did not show significant staining in any of the mouse strains examined. Consistent with mRNA 
expression, the level of SPINK1 protein in pancreas of XX SPINK1 mice was one-third to one-half of those in 
X SPINK1Y mice (Fig. 1e).
The data in Fig. 1 indicate that integration of SPINK1 gene on one of the two X chromosomes results in a 
mosaic pattern of SPINK1 expression through X-chromosome inactivation.
Crossing Spink3 deficient mice with X-SPINK1 rescues the resultant Spink3−/−;XX SPINK1 mice 
from perinatal lethality. Spink3−/− mice die perinatally3, making it impossible to investigate long-term 
effects of Spink3 deficiency. To circumvent this problem, we crossed Spink3+/− mice with X-SPINK1 mice. As we 
previously reported3, pancreatic acinar cells of Spink3−/− mice exhibited prominent vacuolization at P0.5, which 
is not seen in pancreas of Spink3+/− mice (Fig. 2a). The acinar cell vacuolization was prevented in Spink3−/−; 
X SPINK1Y and Spink3−/−;X SPINK1X SPINK1 mice (Fig. 2b), suggesting that ectopic expression of SPINK1 gene com-
pletely compensated for a defect caused by Spink3 deficiency. Notably, in Spink3−/−;XX SPINK1 mice at P0.5 approx-
imately half of all acinar cells exhibited vacuolization, whereas the other half appeared normal (Fig. 2b). We 
further used transmission electron microscopy to examine acinar cell morphology in Spink3−/− and Spink3−/−;XX 
SPINK1 mice at P0.5 in greater detail. The cytoplasmic vacuolization was prominent in all acinar cells in Spink3−/− 
pancreas, whereas in the pancreas of Spink3−/−;XX SPINK1 mice approximately one-half of acinar cells exhibited 
vacuolization and the rest appeared normal (Fig. 2c). As we previously reported3,14,15, the fact that large numbers 
of these vacuoles contain cytoplasmic constituents, in particular organelle remnants, indicates their autophagic 
nature. Further, many vacuoles contain poorly/incompletely degraded cargo, suggesting a defect in later stages of 
the autophagy process.
Of note, the histologically normal (i.e., without vacuoles) acinar cells in P0.5 Spink3−/−;XX SPINK1 pancreas 
expressed SPINK1 mRNA as shown by ISH (Fig. 2d; delineated by black dashed line); in contrast, acinar cells that 
exhibited massive vacuolization did not express SPINK1 mRNA (Fig. 2d; delineated by red dashed line). Together 
with our previous findings3, these results indicate that the one-half of acinar cells in Spink3−/−;XX SPINK1 mice 
that do not express SPINK1 (due to X-chromosome inactivation) develop prominent vacuolization whereas the 
other half, which do express SPINK1, are devoid of these vacuoles. Surprisingly, acinar cells filled with numerous 
vacuoles in pancreas of Spink3−/−;XX SPINK1 mice at P0.5 disappeared at one week after birth (Fig. 2e), suggest-
ing that such cells might have been eliminated during this period. How exactly these cells die out remains to be 
determined; with TUNEL, we did not detect apoptotic acinar cells in either Spink3−/− or Spink3−/−;XX SPINK1 mice 
(Fig. S2).
Of note, the number of ductal-like cells forming so-called “tubular structures” dramatically increased in 
pancreas of 1-week-old Spink3−/−;XX SPINK1 mice (Fig. 2e). Moreover, these cells were positive for both amyl-
ase and cytokeratins (Fig. 2f), suggesting they derived from SPINK1-positive acinar cells through acinar-ductal 
metaplasia16.
Spink3−/−;XX SPINK1 mice spontaneously develop pancreatitis characterized by chronic inflam-
mation and fibrosis. We investigated the development of pancreatic damage, and the underlying mecha-
nisms, in Spink3−/− and Spink3−/−;XX SPINK1 mice. The inappropriate increase in pancreatic trypsin activity is a 
hallmark of both human and experimental pancreatitis17,18. We find that pancreatic trypsin activity was dramat-
ically upregulated in Spink3−/− mice at P0.5 (compared to wild type or Spink3+/− mice) and that this increase 
was ~3 times less in Spink3−/−;XX SPINK1 mice (Fig. 3a). Moreover, there was essentially no increase in pancreatic 
trypsin activity in Spink3−/−;X SPINK1Y mice (Fig. 3a), indicating that human SPINK1 can compensate for the loss 
of trypsin inhibition in Spink3−/− mice.
Proinflammatory cytokines, such as Il6 and Il1b, and the chemokine Ccl2/Mcp-1 (monocyte chemotactic 
protein-1) were upregulated in pancreas of Spink3−/− and Spink3−/−;XX SPINK1 mice at P0.5 (Fig. 3b). In addition, the 
expression of genes associated with ER stress, such as Bip/Grp78 and Chop, was upregulated in pancreas of Spink3−/− 
and Spink3−/−;XX SPINK1 mice compared to Spink3+/− or Spink3+/−;XX SPINK1 mice (Fig. 3c). In these (and other) 
measurements we used Spink3+/−;XX SPINK1 and Spink3+/− mice as controls for, respectively, Spink3−/−;XX SPINK1  
and Spink3−/− to analyze the effects of mosaic expression of SPINK1 in rescuing Spink3−/− mice from perina-
tal lethality and the development of pancreatic injury in Spink3−/−;XX SPINK1 mice; and because Spink3+/− mice 
have normal phenotype. Other mouse strains which can also serve as controls, such as Spink3−/−;X SPINK1Y or 
Spink3−/−; X SPINK1X SPINK1, express SPINK1 in all cells; as noted, these mice do not show any histological or other 
abnormalities (Figs 2b and 3a; and data below).
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We next measured the changes in autophagy markers in pancreas of Spink3−/−;XX SPINK1 mice. The conversion 
of microtubule-associated protein 1 light chain 3 (LC3) from the cytosolic LC3-I to the membrane LC3-II form 
that uniquely localizes to autophagic vacuoles7 was increased in pancreas of Spink3−/− and (to a lesser extent) 
Spink3−/−;XX SPINK1 mice at P0.5, compared to that in Spink3+/− and Spink3+/−;XX SPINK1 mice (Fig. 3d). These data 
are consistent with acinar cell vacuolization we find in Spink3−/− and Spink3−/−;XX SPINK1 mice (Fig. 2b–d). At the 
same time, p62/SQSTM1, a protein which both mediates autophagy and is degraded by autophagy19, disappeared 
in pancreas of Spink3−/− and Spink3−/−;XX SPINK1 mice (Fig. 3d). Of note, a recent study20 has shown that p62 
accumulates in pancreas of mice with pancreas-specific knockout of the kinase IKKα (IkkaΔpan mice), mediating 
the development of spontaneous pancreatitis in this genetic model. Our data in Fig. 3d indicate that, in contrast, 
p62 does not mediate the development of pancreatitis in Spink3−/−;XX SPINK1 mice.
Figure 2. Crossing Spink3 deficient mice with X-SPINK1 rescues the resultant Spink3−/−;XX SPINK1 mice 
from perinatal lethality. (a,b) Hematoxylin and eosin (H&E)-stained pancreatic tissue sections from mice of 
the indicated genotype at P0.5. The lower rows in (a,b) show enlarged images of the upper panels. Scale bars, 
50 μ m. (c) Electron micrographs of pancreata of mice of the indicated genotype at P0.5. The lower row shows 
enlarged images of the areas designated by white boxes in the upper panels. ZG, zymogen granule; V, vacuole; 
N, nucleus. Scale bars, 2 μ m. (d) Adjacent pancreatic tissue sections from Spink3−/−;XXSPINK1 at P0.5 were 
analyzed by H&E staining and ISH. Acinar cells expressing SPINK1 are delineated by black dashed lines, and 
those with no SPINK1 mRNA expression, by red dashed lines. Scale bars, 10 μ m. (e) H&E staining of pancreatic 
tissue sections from mice of the indicated genotype at 1 week. Arrowheads indicate tubular structures. Insets 
show 2.5x-enlarged areas. Scale bars, 50 μ m. (f) Cells positive for both amylase and pan-cytokeratin in pancreas 
of Spink3−/−;XX SPINK1 mice at 1 week. Pancreatic tissue sections from mice of the indicated genotype were 
immunostained using anti-amylase (red) or anti-pan-cytokeratin (green) antibodies. Scale bars, 50 μ m.
www.nature.com/scientificreports/
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Figure 3. Pancreas damage in Spink3−/−;XX SPINK1 mice at birth. (a) Trypsin activity in pancreas of mice 
of the indicated genotype at P0.5 was measured by a fluorogenic enzymatic assay (see Methods). Values 
are means ± SEM (n = 4–6 mice). **P < 0.01. (b,c) mRNA expression of proinflammatory cytokines and 
chemokines, and ER stress markers in pancreas of mice of the indicated genotype was analyzed by qPCR. Values 
are means ± SEM (n = 4 mice). *P < 0.05; **P < 0.01. (d) Autophagy markers LC3 and p62/SQSTM1 were 
analyzed by immunoblotting in pancreas of mice of the indicated genotype. The LC3-II/LC3-I band intensity 
ratio was measured by densitometry and normalized to that in Spink3+/− pancreas. Values are means ± SEM 
(n = 4–6 mice). **P < 0.01.
www.nature.com/scientificreports/
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Although Spink3−/− mice die within 2 weeks after birth3, all Spink3−/−;X SPINK1Y (male) and Spink3−/−;X SPINK1X SPINK1 
(female) mice grew normally and were healthy at 8 weeks (Fig. 4a,b). Approximately 80% of Spink3−/−;XX SPINK1 
(female) mice survived and exhibited mildly, but significantly, retarded body weight gain compared to Spink3+/− 
and Spink3−/−;X SPINK1X SPINK1 mice (Fig. 4a,b). Macroscopically, the pancreas of Spink3−/−;XX SPINK1 mice at 8 
weeks was atrophic compared to that of Spink3+/−;XX SPINK1 mice (Fig. 5a). Spink3−/−;XX SPINK1 mice gradually 
developed chronic pancreatitis, manifested by loss of acinar cells, intralobular fibrosis, and dilatation of inter-
lobular ducts with protein plugs (Figs 5b and S3, and Supplementary Table 1). In contrast to Spink3−/−;XX SPINK1 
mice, there were no histopathological alterations in pancreas of Spink3−/−;X SPINK1Y and Spink3−/−;X SPINK1X mice 
even at later age (13 weeks; Fig. S4).
Large number of inflammatory cells including macrophages, neutrophils, and monocytes infiltrated the pan-
creas, consistent with dramatic upregulation of proinflammatory cytokines and chemokines (Fig. 5c,d). Moreover, 
the expression of genes induced by ER stress (Bip/Grp78 and Chop), and those induced by oxidative stress (such 
as Hmox1 and Nqo1) increased in pancreas of Spink3−/−;XX SPINK1 mice compared to Spink3+/−;XX SPINK1mice 
(Fig. 5e,f). Of note, the upregulation of all these genes was much greater at 8 weeks (Fig. 5d–f) than at P0.5 
(Fig. 3b,c), illustrating progressive development of pancreatitis in Spink3−/−;XX SPINK1 mice. The reduced form of 
glutathione (GSH) protects cellular components from reactive oxygen species such as free radicals and peroxides. 
The pancreatic GSH level increased in Spink3−/−;XX SPINK1 mice (Fig. 5g), indicating a protective response.
As stated above (Fig. 4b), body weight of Spink3−/−;XX SPINK1 mice was somewhat lower than that of 
Spink3+/−;XX SPINK1 and Spink3−/−;X SPINK1X SPINK1 mice, suggesting a mild exocrine pancreas dysfunction. We did 
not observe dramatic changes in blood biochemical parameters of Spink3−/−;XX SPINK1 mice at 8 weeks (Fig. S5), 
except for 50% decrease in blood triglycerides. Glucose level in blood was not altered; a modest decrease in serum 
amylase (Fig. S5) may reflect loss of acinar tissue.
Precancerous changes in the pancreas of Spink3−/−;XX SPINK1 mice. Chronic pancreatitis is associ-
ated with a stromal reaction including proliferation and activation of pancreatic stellate cells (PSCs), a type of mes-
enchymal cells activation of which mediates the development of pancreatic fibrosis21. PSCs are desmin-positive; 
the number of desmin-positive cells greatly increased in pancreas of Spink3−/−;XX SPINK1 mice compared to 
Spink3+/−;XX SPINK1 mice (Fig. 6a), and they accumulated around ducts. We further found increased staining for 
α -smooth muscle actin (α SMA), a marker of activated PSCs (Fig. 6a). IB analysis (Fig. 6b) confirmed the increases 
in desmin and α SMA. Moreover, the levels of products of proto-oncogenes implicated in the development of 
pancreatic cancer, such as EGFR, HER2, and RAS, dramatically increased in pancreas of Spink3−/−;XX SPINK1  
mice at 8 weeks (Fig. 6c). The expression of EGFR was not only detected in acinar-like cells but also in the epithe-
lial cells of hyperplastic ducts (Fig. 6d). Staining for Ki67, a proliferation marker, also dramatically increased in 
8-week-old Spink3−/−;XX SPINK1 mice (Fig. 6e). Together, these data indicate that chronic pancreatitis that develops 
Figure 4. Spink3−/−;XX SPINK1 mice exhibit mild growth retardation. (a) Survival curves of male and female 
mice of the indicated genotype. P value, as compared to the wild type (Spink3+/+), was calculated by the log rank 
test. (b) Body weight gain of mice of the indicated genotype. Values are means ± SEM. *P < 0.05.
www.nature.com/scientificreports/
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in Spink3−/−;XX SPINK1 mice induces pre-cancerous changes, suggestive of PanIN lesions’ formation. However, we 
did not detect the development of pancreatic adenocarcinoma even in 12-month-old Spink3−/−;XX SPINK1 mice 
(data not shown).
Discussion
In the present study, we have developed a novel method to express a target gene in a mosaic pattern through its’ 
specific integration onto the X-chromosome by using Cre-loxP technology. Consistent with our hypothesis, female 
X-SPINK1 mice, in which one of the two copies of X-chromosome is inactivated, express human SPINK1 mRNA 
in a mosaic pattern. Crossing Spink3 deficient mice with X-SPINK1 rescues the resultant Spink3−/−;XX SPINK1  
mice from perinatal lethality, but they develop chronic pancreatitis. Our results indicate that the one- half of aci-
nar cells in pancreas of Spink3−/−;XX SPINK1 mice that do not express SPINK1 (due to X chromosome inactivation) 
display prominent vacuolization, whereas the other half harboring SPINK1 on the active X chromosome are his-
tologically normal. In general, the method we have developed should be useful to rescue mice lacking an essential 
survival gene, and to monitor long-term effects of insufficient gene function.
A number of recent studies have indicated the involvement of lysosomal and autophagic dysfunction in the 
pathogenesis of pancreatitis, and in particular, the development of chronic inflammation15,20,22–26. For example, a 
recent study20 has shown that pancreas specific deletion of Ikka causes defective autophagy completion, resulting 
in accumulation of p62 which mediates the ER and oxidative stresses, leading to chronic inflammation and other 
pancreatitis responses in the IkkaΔpan genetic model. In contrast, we here find that p62 protein is dramatically 
Figure 5. Spink3−/−;XX SPINK1 mice spontaneously develop chronic pancreatitis. (a) Macroscopic analysis of 
Spink3+/−;XX SPINK1 and Spink3−/−;XX SPINK1 mice at 8 weeks. Dashed lines delineate the pancreas. (b) Pancreatic 
tissue sections from mice of the indicated genotype at 8 weeks were stained with H&E (upper panels) or Azan 
[for collagen (dark blue); lower panels]. Scale bars, 100 μ m. (c) Pancreatic cryosections from mice of the 
indicated genotype were stained for immune cell markers CD68, F4/80, Ly-6G, or CD11b (brown). Right-
column panels show enlarged images of the boxed areas in the corresponding middle-column panels. Scale bars, 
50 μ m. (d–f) qPCR analysis of gene expression for (d) proinflammatory cytokines and chemokines, (e) ER and 
(f) oxidative stress markers. (g) Reduced glutathione (GSH) levels in pancreas of mice of the indicated genotype 
at 8 weeks. Values are means ± SEM (n = 4–6 mice). *P < 0.05; **P < 0.01.
www.nature.com/scientificreports/
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down-regulated in pancreas of Spink3−/− and Spink3−/−;XX SPINK1 mice (at P0.5) and, therefore, is unlikely to 
mediate the development of chronic pancreatitis in the “X-SPINK1” genetic model. Interestingly, recent studies 
(e.g., ref. 26 and our unpublished data) show that p62 level in pancreas can be regulated not only through its 
autophagic degradation but also through changes in mRNA expression. Taken together, the accumulation of 
abnormally large autophagic vacuoles (many of which contain poorly degraded cargo), decrease in p62, and 
increased LC3-II level suggest that autophagy in pancreas of Spink3−/−;XX SPINK1 mice might be upregulated 
but also impaired. Of note, these two effects on autophagy are not mutually exclusive; in particular, both occur 
in acute cerulein pancreatitis15,24,27. The characterization of pancreatic autophagy in Spink3−/−;XX SPINK1 mice 
requires detailed investigation.
Accumulating studies have shown that acute acinar cell injury caused by aberrant activation of trypsin is not 
sufficient to develop chronic pancreatitis in mice28. Also, we did not find evidence for apoptotic death of acinar 
cells in pancreas of Spink3−/−;XX SPINK1 mice; it remains to be determined how exactly the cells that do not express 
SPINK1 are eliminated in these mice. Our findings presented in another study (manuscript in preparation) indi-
cate contribution of RIPK3-dependent necroptosis29 to this process. In addition to loss of acinar tissue, chronic 
pancreatitis is characterized by persistent inflammation and fibrosis, along with tissue remodeling5. Activated 
PSCs are considered critical for the development of fibrosis in chronic pancreatitis, by producing extracellular 
matrix proteins as well as proinflammatory cytokines and chemokines5. Importantly, we found positive staining 
for α SMA, a PSCs activation marker, indicating that PSCs mediate fibrosis in Spink3−/−;XX SPINK1 mice. Thus, 
Spink3−/−;XXSPINK1 mice reproduce key responses of human chronic pancreatitis. Further, chronic pancreatitis 
that develops in Spink3−/−;XX SPINK1 mice is associated with increases in proliferation and pancreatic levels of 
proteins implicated in the development of pancreatic cancer, such as EGFR, HER2, and RAS.
In conclusion, we have developed a novel method thereby mice lacking a gene essential for cell survival can 
be rescued by expressing this gene on the X chromosome. We applied this method, utilizing X-chromosome 
inactivation, to generate Spink3−/−;XX SPINK1 mice in which perinatal lethality is rescued and SPINK1 function is 
partially restored. These mice develop spontaneous pancreatitis, revealing a critical role of SPINK1 in regulating 
normal autophagy in the exocrine pancreas. Our results, together with recent findings from our groups as well as 
others3,14,15,20,24,26,27, indicate that defects in autophagy function lead to pancreatitis.
Figure 6. Pre-cancerous changes in pancreas of Spink3−/−;XXSPINK1 mice. (a) Pancreatic tissue sections  
from mice of the indicated genotype at 8 weeks were immunostained for desmin or α SMA (brown). Scale bars, 
50 μm. Du, duct. (b,c) Up-regulation of (b) stellate cell markers and (c) proto-oncogene products in pancreas 
of Spink3−/−;XX SPINK1 mice at 8 weeks (immunoblot). (d) Pancreatic tissue sections from mice of the indicated 
genotype at 8 weeks were immunostained for EGFR (brown). Scale bars, 100 μ m. (e) Ki67 staining of pancreatic 
tissue sections and Ki67 labeling index at 8 weeks. Scale bars, 50 μ m. Values are means ± SEM (n = 5 mice). 
**P < 0.01.
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Methods
Antibodies. The antibodies used in this study were against insulin (Santa Cruz; SC; sc-9168), amylase 
(SC; sc-12821), Dia3 (SC; sc-10892), glucagon (Dako, A0565), desmin (Dako, M0760), α SMA (Dako, A0851), 
cytokeratin (Nichirei, 422061), LC3 (Cell Signaling Technology; CST, #2775), p62 (CST, #5114), ERK (CST, 
#9102), Spink1 (CST, #2744), CD68 (Serotec, MCA1957), CD11b (eBioscience, 11-0112-81), F4/80 (eBiosci-
ence, 14-4801-81), Ly-6G (TONBO biosciences, 70-5931), Ki-67 (Novocastra, NCL-Ki67p), EGFR (Proteintech, 
18986-1-AP), HER2 (Proteintech, 18299-1-AP), SPINK1 (Abnova, H00006690-M01), Ras (Millipore, #05-516), 
glyceraldehyde-3-phosphate dehydrogenase (Abcam, ab8245), actin (Sigma, 20-33), and tubulin (Sigma, T5168).
Animal use. Mice were kept under specific-pathogen-free (SPF) conditions with free access to food and 
water in a 12 hours light/dark cycle. Spink3−/− mice were described previously3. C57BL/6 N mice were purchased 
from the Clea Japan. All animal experiments were performed with the approval of the Kumamoto University 
Institutional Animal Care and Use Committee (A27-092). All methods were carried out in accordance with the 
relevant guidelines of the Kumamoto University, including any relevant details.
Generation of SPINK1 minigene X-chromosome knock-in mice. SPINK1 minigene was described 
elsewhere12. For the present study, we have generated a replacement vector30 containing loxJTZ17-CAG-promoter 
(pCAGGS)- SPINK1 minigene-polyA (pA)- phosphoglycerate kinase-1 promoter (PGK)-puromycin resistance 
gene (PAC)-pA (PGK-PAC-pA)-lox2272. The TT2 ES cell line contains a knocked-out Diap2 allele located on 
X-chromosome, in which Diap2 was targeted by the PGK-neomycin resistance gene (neo) fragment flanked by 
the mutant lox sites, lox71 and lox2272 (gene trap vector) (Fig. 1a). For co-electroporation with pCAGGS-Cre 
(a Cre recombinase gene expression vector13) and replacement vector plasmids, we used 20 μ g of each plasmid 
and 1 × 107 Diap2+/− ES cells. The cells were co-electroporated using a Bio-Rad Gene Pulser, and then cultured 
for 48 hours in a standard medium supplemented with 2 μ g/ml puromycin (Sigma). Selection was maintained 
for 5 days, and then colonies were picked into 48-well plates and expanded for storage. The puromycin-resistant 
colonies were analyzed by Southern blotting and by PCR to select ES cell lines showing successful integration of 
pCAGGS-SPINK1 minigene-pA sequence. Positive clones were aggregated with ICR morula according to the 
previously described protocol30. Germline transmission was obtained in three mouse lines, resulting in X-SPINK1 
mice, which were back-crossed onto C57BL/6 N mice for at least 5 generations.
Reverse transcriptase (RT)-PCR analysis. Total RNA was isolated using the RNeasy Mini Kit 
(Qiagen). cDNA was synthesized using qPCR RT Kit (Toyobo). For the detection of Ccl2 (Mm00441242), Il6 
(Mm00446190), and Il1b (Mm00434228) mRNA, TaqMan Gene Expression Assays on the AB 7500 Real Time 
PCR System (Applied Biosystems) was used. Other PCR primers are described in the Supplementary Table 2. 
Densitometric quantification was done using Image J software (http://rsb.info.nih.gov/ij/).
In situ hybridization (ISH). Pancreases were fixed in 4% paraformaldehyde phosphate buffer solution for 
48 hours at room temperature and cut into 4-μ m sections. The sections were mounted on glass slides and pro-
cessed sequentially according to a standard protocol. To prepare the digoxigenin (DIG)-labeled RNA sense (con-
trol) and antisense riboprobes (Roche), total RNA was extracted from human or mouse pancreas and then each 
complementary DNA (cDNA) template was amplified using reverse transcriptase (RT)-PCR. Primers applied 
in the RT-PCR reactions were as follows: primer hPSTI1 (CGTGGTAAGTGCGGTGCAGT) located in the first 
exon of SPINK1 gene; primer hPSTI2 (CGCGGTGACCTGATGGGATT) located in the fourth exon of SPINK1 
gene, and primer mPsti1 (AGTTCTTCTGGCTTTTGCACCC) located in the first exon of Spink3 gene; primer 
mPsti25 (TTCAACGAACCCACGTTGCCTT) located in the fourth exon of Spink3 gene. ISH analysis was per-
formed with a Ventana XT System Discovery (Roche). Nuclear Fast Red staining was performed after ISH.
Histological and Immunohistochemical analysis. For histological analysis, tissues were fixed overnight 
in 15% formalin (Wako), embedded in paraffin, sectioned, and stained using standard procedure for H&E, Azan, 
or Sirius red. Immunohistochemistry was performed by using the antibodies listed above.
Transmission electron microscopy. Anesthetized mice were fixed by intracardial perfusion with 2% glut-
araldehyde and 2% paraformaldehyde in 0.1 M phosphate buffer, pH 7.4. Slices of thus fixed tissues were postfixed 
with 2% OsO4, dehydrated in ethanol and embedded in Epok 812 (Okenshoji Co.). Ultrathin sections were cut 
with a ultramicrotome (ultracut N or UC6: Leica), stained with uranyl acetate and lead citrate, and were examined 
on a Hitachi HT7700 or JEOL JEM-1230 electron microscope.
Immunoblot analysis. Pancreas or other tissues were disrupted in the Multi-Beads Shocker system 
(Yasui-Kikai), and homogenized in a RIPA buffer [150 mM M NaCl, 50 mM Tris-HCl (pH 7.2), 1% deoxycholic 
acid, 1% Triton X-100, 0.1% SDS, 1 mM phenylmethylsulfonyl fluoride, and protease inhibitor cocktail (1:100 
dilution; Nacalai tesque)]. The homogenates were subjected to SDS-PAGE and transferred onto Immobilon poly-
vinylidene difluoride membranes (Millipore). The membranes were blotted using the indicated antibodies, devel-
oped with ECL Western Blotting Detection Reagents, and analyzed in a LAS4000 (GE Healthcare Life Sciences). 
Quantification of the LC3-II to LC3-I ratio was performed with ImageJ software.
Trypsin activity. To measure trypsin activity, mouse pancreas was disrupted using the Multi-Beads 
Shocker system (Yasui Kikai), and in buffer containing 5 mM 2-Morpholinoethanesulfonic acid (pH 6.5), 
1 mM MgSO4, and 250 mM sucrose. Trypsin activity in homogenates was measured fluorimetrically using 
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Boc-Gln-Ala-Arg-MCA (Peptide Institute. Inc.) as a substrate, in the Infinite 200 PRO (Tecan), according to the 
method of Kawabata et al.31. Trypsin activity in each sample was determined using a standard curve for purified 
trypsin (T1426, Sigma).
Terminal deoxynucleotidyl transferase–mediated deoxyuridine triphosphate nick-end labeling 
(TUNEL) assay. This was performed by using in situ apoptosis detection kit (Wako).
GSH content measurement. Pancreas were homogenized in 5% methacholic acid buffer. After homog-
enization, the lysates were centrifuged at 2800 g and the supernatants were collected and used for GSH assays. 
Determination of GSH was performed with the GSH assay kit (Oxis International) according to the manufacturer’s 
instructions. To normalize GSH contents per mg protein of liver extracts, we solubilized the pellets in a RIPA 
buffer and measured protein content with the Bradford assay (Pierce).
Statistical analysis. Data in graphs are expressed as means ± standard error of mean (SEM) from 4 or more 
experiments per group, and each experiment was performed at least twice. Statistical analysis was performed 
by using unpaired Student’s t test or one-way analysis of variance (ANOVA) test, as appropriate, with GraphPad 
Prism 6 (GraphPad Software, Inc.). P < 0.05 was considered to be statistically significant.
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